{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:42:37Z","timestamp":1793853757463,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1245\/s10434-021-10725-4","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:14:53Z","timestamp":1630718093000},"page":"885-892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nomogram to Predict Incomplete Cytoreduction for Pseudomyxoma Peritonei"],"prefix":"10.1245","volume":"29","author":[{"given":"Mingjian","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianzong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"10725_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"5","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;5:511\u20139.","journal-title":"Int J Hyperthermia."},{"issue":"2","key":"10725_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0002-9610(37)90763-3","volume":"36","author":"CH Weaver","year":"1937","unstructured":"Weaver CH. Mucocele of appendix with pseudomucinous degeneration. Am J Surg. 1937;36(2):523\u20136.","journal-title":"Am J Surg."},{"key":"10725_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"2","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population-based study. Eur J Surg Oncol. 2008;2:196\u2013201.","journal-title":"Eur J Surg Oncol."},{"key":"10725_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/ejso.2000.1038","volume":"3","author":"PH Sugarbaker","year":"2001","unstructured":"Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;3:239\u201343.","journal-title":"Eur J Surg Oncol."},{"key":"10725_CR5","first-page":"281","volume":"4","author":"Y Li","year":"2014","unstructured":"Li Y, Yu Y, Liu Y. Report on the 9(Th) international congress on peritoneal surface malignancies. Cancer Biol Med. 2014;4:281\u20134.","journal-title":"Cancer Biol Med."},{"key":"10725_CR6","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"20","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;20:2449\u201356.","journal-title":"J Clin Oncol."},{"key":"10725_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"1","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;1:29\u201342.","journal-title":"Ann Surg."},{"key":"10725_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","volume":"2","author":"PL Wagner","year":"2013","unstructured":"Wagner PL, Austin F, Sathaiah M, et al. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013;2:506\u201314.","journal-title":"Ann Surg Oncol."},{"key":"10725_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","volume":"5","author":"P Taflampas","year":"2014","unstructured":"Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Preoperative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol. 2014;5:515\u201320.","journal-title":"Eur J Surg Oncol."},{"key":"10725_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1463-1318.2005.00773.x","volume":"4","author":"F Alexander-Sefre","year":"2005","unstructured":"Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis. 2005;4:382\u20136.","journal-title":"Colorectal Dis."},{"key":"10725_CR11","first-page":"173","volume":"2","author":"JL Koh","year":"2013","unstructured":"Koh JL, Liauw W, Chua T, Morris DL. Carbohydrate antigen 19\u20139 (CA 19\u20139) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Gastrointest Oncol. 2013;2:173\u201381.","journal-title":"J Gastrointest Oncol."},{"key":"10725_CR12","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","volume":"8","author":"TD Yan","year":"2007","unstructured":"Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;8:2289\u201399.","journal-title":"Ann Surg Oncol."},{"key":"10725_CR13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","volume":"7","author":"N Ansari","year":"2016","unstructured":"Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol. 2016;7:1035\u201341.","journal-title":"Eur J Surg Oncol."},{"key":"10725_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jso.23329","volume":"1","author":"S Kusamura","year":"2013","unstructured":"Kusamura S, Hutanu I, Baratti D, Deraco M. Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. J Surg Oncol. 2013;1:1\u20138.","journal-title":"J Surg Oncol."},{"key":"10725_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s10147-019-01592-x","volume":"4","author":"S Hiraide","year":"2020","unstructured":"Hiraide S, Komine K, Sato Y, et al. Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei. Int J Clin Oncol. 2020;4:774\u201381.","journal-title":"Int J Clin Oncol."},{"key":"10725_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"1","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A Consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;1:14\u201326.","journal-title":"Am J Surg Pathol."},{"key":"10725_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fpsyt.2020.00282","volume":"11","author":"Y Yi","year":"2020","unstructured":"Yi Y, Ding L, Wen H, Wu J, Makimoto K, Liao X. Is Barthel Index suitable for assessing activities of daily living in patients with dementia? Front Psychiatry. 2020;11:282.","journal-title":"Front Psychiatry."},{"key":"10725_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ejso.2016.10.009","volume":"2","author":"GH Tan","year":"2017","unstructured":"Tan GH, Novo CA, Dayal S, et al. The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin. Eur J Surg Oncol. 2017;2:388\u201394.","journal-title":"Eur J Surg Oncol."},{"key":"10725_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jso.21388","volume":"4","author":"M Deraco","year":"2009","unstructured":"Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;4:321\u20138.","journal-title":"J Surg Oncol."},{"key":"10725_CR20","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"18","author":"FJ Harrell","year":"1982","unstructured":"Harrell FJ, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;18:2543\u20136.","journal-title":"JAMA."},{"key":"10725_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/ijgc-00009577-200209000-00007","volume":"5","author":"A Ayhan","year":"2002","unstructured":"Ayhan A, Taskiran C, Celik C, Yuce K, Kucukali T. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int J Gynecol Cancer. 2002;5:448\u201353.","journal-title":"Int J Gynecol Cancer."},{"key":"10725_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/145749691009900406","volume":"4","author":"P Jarvinen","year":"2010","unstructured":"Jarvinen P, Lepisto A. Clinical presentation of pseudomyxoma peritonei. Scand J Surg. 2010;4:213\u20136.","journal-title":"Scand J Surg."},{"key":"10725_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1245\/s10434-019-07626-y","volume":"1","author":"MY Zaidi","year":"2020","unstructured":"Zaidi MY, Lee RM, Gamboa AC, et al. Preoperative risk score for predicting incomplete cytoreduction: a 12-institution study from the US HIPEC Collaborative. Ann Surg Oncol. 2020;1:156\u201364.","journal-title":"Ann Surg Oncol."},{"key":"10725_CR24","first-page":"640","volume":"10","author":"S Anand","year":"2020","unstructured":"Anand S, Burkenroad A, Glaspy J. Workup of anemia in cancer. Clin Adv Hematol Oncol. 2020;10:640\u20136.","journal-title":"Clin Adv Hematol Oncol."},{"key":"10725_CR25","unstructured":"Yu B, Raj MS. Pseudomyxoma Peritonei. vol 11. Treasure Island, FL: StatPearlsPublishing; 2019. p. 1\u20139."},{"key":"10725_CR26","first-page":"863","volume":"131","author":"JH Kim","year":"2014","unstructured":"Kim JH, Jun KH, Jung H, Park IS, Chin HM. Prognostic value of preoperative serum levels of five tumor markers (carcinoembryonic antigen, CA19-9, alpha-fetoprotein, CA 72\u20134, and CA 125) in gastric cancer. Hepatogastroenterology. 2014;131:863\u20139.","journal-title":"Hepatogastroenterology."},{"key":"10725_CR27","doi-asserted-by":"publisher","first-page":"188409","DOI":"10.1016\/j.bbcan.2020.188409","volume":"2","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, et al. Roles of CA 19\u20139 in pancreatic cancer: biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer. 2021;2:188409.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"10725_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.pmbts.2018.12.005","volume":"162","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang M, Bai X, Li C, Zhang L. Increased serum CA 724 levels in patients suffering gout vs cancers. Prog Mol Biol Transl Sci. 2019;162:177\u201386.","journal-title":"Prog Mol Biol Transl Sci."},{"key":"10725_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.pmbts.2018.12.007","volume":"162","author":"H Dou","year":"2019","unstructured":"Dou H, Sun G, Zhang L. CA 242 as a biomarker for pancreatic cancer and other diseases. Prog Mol Biol Transl Sci. 2019;162:229\u201339.","journal-title":"Prog Mol Biol Transl Sci."},{"key":"10725_CR30","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jso.23878","volume":"6","author":"MR Torkzad","year":"2015","unstructured":"Torkzad MR, Casta N, Bergman A, Ahlstrom H, Pahlman L, Mahteme H. Comparison between MRI and CT in Prediction of Peritoneal Carcinomatosis Index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. J Surg Oncol. 2015;6:746\u201351.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10725-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:07:01Z","timestamp":1641222421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10725-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10725"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10725-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}